SCHEMBL8445342

SCHEMBL8445342

CCOc1cc(C(=O)Nc2ccccc2)c(Oc2ccccn2)c(NS(=O)(=O)c2ccc(SC)cc2)c1Oc1cccc(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 1/20 0.58
RXFP1 Q9HBX9 9/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
HPGD P15428 3/20 0.44
POLB P06746 2/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 2/20 0.44
THRB P10828 1/20 0.42
AVPR2 P30518 2/20 0.42
GPR27 Q9NS67 2/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CNR1 P21554 1/20 0.41
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8444967 0.94 EDNRB (0.60) EDNRBRXFP1SMN1; SMN2HPGDPOLB
SCHEMBL8045720 0.80 EDNRB (0.81) EDNRBRXFP1SMN1; SMN2HPGDPOLB
SCHEMBL7946308 0.76 EDNRB (0.85) EDNRBRXFP1SMN1; SMN2HPGDPOLB
SCHEMBL7565899 0.74 EDNRB (1.00) EDNRBRXFP1SMN1; SMN2HPGDPOLB
SCHEMBL7568095 0.71 EDNRB (0.81) EDNRBRXFP1SMN1; SMN2HPGDPOLB
SCHEMBL8445313 0.71 EDNRB (0.44) EDNRBSMN1; SMN2HPGDKMT2ANPSR1
SCHEMBL8443900 0.70 EDNRB (0.47) EDNRBALDH1A1KDM4E
SCHEMBL7949262 0.68 EDNRB (0.58) EDNRBSMN1; SMN2KMT2AALDH1A1
SCHEMBL12197843 0.67 MAPT (0.74) RXFP1SMN1; SMN2LMNATHRBAVPR2
SCHEMBL7565436 0.66 EDNRB (0.82) EDNRBMAPK1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962682-A Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists HOFFMANN-LA ROCHE INC. (US) 1999-10-05 US disclosed